← Browse by Condition
Medical Condition
b cell lymphoblastic leukemia
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT06144606 Phase 2
Recruiting
Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Enrollment
60 pts
Location
United States
Sponsor
H. Lee Moffitt Cancer Center a...
NCT07422337
Recruiting
A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab
Enrollment
300 pts
Location
United States
Sponsor
Arkansas Children's Hospital R...